Story perspectives
Precision Medicine Revolutionizes Liver Transplant Outcomes for HCC
9/14/2025
38 4
1 of 1
Story summary
- Precision medicine plays a crucial role in liver transplantation for hepatocellular carcinoma (HCC).
- Third-generation sequencing improves patient selection and treatment, enhancing post-transplant outcomes.
- Liquid biopsies allow non-invasive monitoring of circulating tumor DNA, essential for personalized care.
- Understanding tumor genetics helps predict recurrence and tailor post-operative treatment.
- Challenges include the need for investment and standardized protocols for clinical integration.
